Moxetumomab pasudotox in heavily pretreated patients with relapsed/refractory hairy cell leukemia: Results of a pivotal international study.
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Robert J. Kreitman, Claire Dearden, Pier Luigi Zinzani, Julio Delgado, Tadeusz Robak, Phillipp D. Le Coutre, Bjorn T. Gjertsen, Xavier Troussard, Guiseppe Saglio, Gail J. Roboz, Lionel Karlin, Douglas Edward Gladstone, Kemal Balic, Nathan Standifer, Peng He, Shannon Marshall, Wyndham Hopkins Wilson, Ira Pastan, Nai-Shun Yao, Francis J. Giles, on behalf of the Study 1053 investigators
Institutions: National Institutes of Health, National Cancer Institute, Royal Marsden NHS Foundation Trust, University of Bologna, Hospital Clínic de Barcelona, Copernicus Memorial Hospital, Medical University of Lodz, Charité - Universitätsmedizin Berlin, Haukeland University Hospital, Centre Hospitalier Universitaire de Caen Normandie, University of Turin, Weill Cornell Medical Center, Hôpital Lyon Sud, Sidney Kimmel Comprehensive Cancer Center
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2891958134